-
Provisions for Unannounced Inspection of Drugs and Medical Devices (Decree No.14 of China Food and Drug
2019-10-11
The Provisions for Unannounced Inspection of Drugs and Medical Devices, adopted at the Executive Meeting of China Food and Drug Administration on May 18, 2015, is hereby promulgated and shall be effective as of September 1, 2015.
-
Rules for Classification of Medical Devices
2019-10-11
The Rules for Classification of Medical Devices, adopted at the executive meeting of China Food and Drug Administration on June 3, 2015, is hereby promulgated and shall be effective as of January 1, 2016.
-
Provisions for Instructions and Labels of Medical Devices (Decree No.6 of China Food and Drug Administration)
2019-10-11
The Provisions for Instructions and Labels of Medical Devices, adopted at the executive meeting of China Food and Drug Administration on June 27, 2014, is hereby promulgated and shall be effective as of October 1, 2014.
-
Provisions for Drug Recall (SFDA Decree No. 29) (Abolished)
2019-10-11
The Provisions for Drug Recall was deliberated and adopted by the executive meeting of the State Food and Drug Administration on December 6, 2007 and now is issued. These Provisions shall go into effect as of the date of promulgation.
-
Provisions for the Lot Release of Biological Products (CFDA Decree No.39) (Abolished)
2019-10-11
Provisions for the Lot Release of Biological Products, deliberated and adopted at the executive meeting of China Food and Drug Administration on December 20, 2017, is hereby promulgated and shall go into effect as of February 1, 2018.
-
Decree of State Food and Drug Administration
2019-10-10
The Provisions for Drug Importation, adopted by the State Food and Drug Administration and the General Administration of Customs of the People's Republic of China, is hereby promulgated and shall go into effect as of January 1, 2004.